Ticapol Tablet
Marketer
Medipol Pharmaceuticals India Pvt Ltd
Salt Composition
Ticagrelor (90mg)
Overview Ticapol Tablet
CardioGuard tablets are classified as antiplatelet agents, also known as blood thinners. Their function is to inhibit the development of dangerous blood clots within blood vessels, thus lowering the risk of heart attack or stroke in individuals with cardiovascular disease. CardioGuard is also indicated for patients who have recently experienced a heart attack, suffer from unstable angina (severe chest pain), or have undergone coronary stenting. It helps prevent further cardiac events, including subsequent heart attacks, strokes, or clot formation within stents. Concomitant use with aspirin, another antiplatelet medication, will be prescribed by your physician. CardioGuard can be administered with or without food and should be taken consistently at the same time daily. Continuous use is crucial, even in the absence of symptoms, as discontinuation increases the risk of recurrent cardiac events. The most frequent adverse effect is increased bleeding tendency; injuries may bleed more profusely and for longer periods. While typically mild and self-limiting, prolonged bleeding or worsening should be reported to your doctor. Some patients may experience mild shortness of breath, which generally resolves with continued therapy. However, persistent or worsening shortness of breath requires medical attention. CardioGuard is contraindicated in patients with active bleeding (e.g., stomach ulcers, intracranial hemorrhage) or liver disease. Prior to initiating treatment, disclose any such conditions to your physician.
Primary Ingredients of Ticapol Tablet
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Ticapol Tablet
Reducing the risk of cardiovascular events
Major Benefits of Ticapol Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Ticapol Tablet whole; avoid chewing, crushing, or breaking it. While this medication can be taken with or without food, consistency in timing is recommended.
Common Side effects of Ticapol Tablet:
- Bleeding
- Breathlessness
How to use Ticapol Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Ticapol Tablets can be consumed with or without food, although consistent timing is recommended.
How Ticapol Tablet works:
Ticagrelor tablets inhibit platelet aggregation, thus reducing the risk of dangerous blood clots and subsequently lowering the likelihood of a heart attack or stroke.
SAFETY ADVICE
AlcoholCAUTION
Use of Ticapol Tablet with alcohol requires careful consideration. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Ticapol Tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the unborn child. A physician will assess the potential advantages against any risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on Ticapol Tablet use while breastfeeding is lacking. Seek medical advice from your physician.
DrivingSAFE
Driving ability is typically unaffected by TicaPol tablets.
KidneySAFE IF PRESCRIBED
Patients with kidney disease can safely take Ticapol tablets without needing a dosage change. However, data on Ticapol tablet use in patients undergoing renal dialysis is scarce.
LiverCAUTION
Patients with liver impairment should use Ticapol Tablet cautiously, potentially requiring dose modification. Consultation with a physician is advised. Ticapol Tablet is contraindicated in patients exhibiting severe hepatic dysfunction.
What if you forget to take Ticapol Tablet :
Should you forget a Ticapol Tablet dose, take it promptly. However, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Ticapol Tablet
| Label | Value |
|---|---|
| Chemical Classification | Triazolo[1,5-a]pyrimidines |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
| Action Category | ADP receptor antagonists (P2Y12 inhibitors) |


